Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India's drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the country.
The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson's Covid-19 vaccine that works with just one dose for emergency use.
